ArticleMolecular cancer therapeutics2020
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors.
Takahito M Miyake et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleMolecular cancer therapeutics2020
Takahito M Miyake et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.